Literature DB >> 15128772

The inducible costimulator plays the major costimulatory role in humoral immune responses in the absence of CD28.

Woong-Kyung Suh1, Anna Tafuri, Nancy N Berg-Brown, Arda Shahinian, Suzanne Plyte, Gordon S Duncan, Hitoshi Okada, Andrew Wakeham, Bernhard Odermatt, Pamela S Ohashi, Tak W Mak.   

Abstract

CD28 plays crucial costimulatory roles in T cell proliferation, cytokine production, and germinal center response. Mice that are deficient in the inducible costimulator (ICOS) also have defects in cytokine production and germinal center response. Because the full induction of ICOS in activated T cells depends on CD28 signal, the T cell costimulatory capacity of ICOS in the absence of CD28 has remained unclear. We have clarified this issue by comparing humoral immune responses in wild-type, CD28 knockout (CD28 KO), and CD28-ICOS double-knockout (DKO) mice. DKO mice had profound defects in Ab responses against environmental Ags, T-dependent protein Ags, and vesicular stomatitis virus that extended far beyond those observed in CD28 KO mice. However, DKO mice mounted normal Ab responses against a T-independent Ag, indicating that B cell function itself was normal. Restimulated CD4(+) DKO T cells that had been primed in vivo showed decreased proliferation and reduced IL-4 and IL-10 production compared with restimulated CD4(+) T cells from CD28 KO mice. Thus, in the absence of CD28, ICOS assumes the major T cell costimulatory role for humoral immune responses. Importantly, CD28-mediated ICOS up-regulation is not essential for ICOS function in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128772     DOI: 10.4049/jimmunol.172.10.5917

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  T-cell tolerance or function is determined by combinatorial costimulatory signals.

Authors:  Roza Nurieva; Sunil Thomas; Thang Nguyen; Natalia Martin-Orozco; Ying Wang; Murali-Krishna Kaja; Xue-Zhong Yu; Chen Dong
Journal:  EMBO J       Date:  2006-05-25       Impact factor: 11.598

Review 2.  Approaches to studying costimulation of human antiviral T cell responses: prospects for immunotherapeutic vaccines.

Authors:  Lena Serghides; Mariana Vidric; Tania H Watts
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  Expression of inducible co-stimulator in peripheral blood T lymphocytes in the patients with systemic lupus erythematosus.

Authors:  Zhiping Chen; Zhenfu Liu; Shunhua Zheng; Zhihui Liang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

Review 4.  Searching for "signal 2": costimulation requirements of γδ T cells.

Authors:  Julie C Ribot; Ana debarros; Bruno Silva-Santos
Journal:  Cell Mol Life Sci       Date:  2011-05-04       Impact factor: 9.261

5.  Inducible costimulator is required for type 2 antibody isotype switching but not T helper cell type 2 responses in chronic nematode infection.

Authors:  P'ng Loke; Xingxing Zang; Lisa Hsuan; Rebecca Waitz; Richard M Locksley; Judith E Allen; James P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-01       Impact factor: 11.205

6.  VSIG4, a B7 family-related protein, is a negative regulator of T cell activation.

Authors:  Lorenz Vogt; Nicole Schmitz; Michael O Kurrer; Monika Bauer; Heather I Hinton; Silvia Behnke; Dominique Gatto; Peter Sebbel; Roger R Beerli; Ivo Sonderegger; Manfred Kopf; Philippe Saudan; Martin F Bachmann
Journal:  J Clin Invest       Date:  2006-10       Impact factor: 14.808

7.  Generation and characterization of B7-H4/B7S1/B7x-deficient mice.

Authors:  Woong-Kyung Suh; Seng Wang; Gordon S Duncan; Yoshiyuki Miyazaki; Elizabeth Cates; Tina Walker; Beata U Gajewska; Elissa Deenick; Wojciech Dawicki; Hitoshi Okada; Andrew Wakeham; Annick Itie; Tania H Watts; Pamela S Ohashi; Manel Jordana; Hiroki Yoshida; Tak W Mak
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

8.  Suppression of T cell costimulator ICOS by Delta9-tetrahydrocannabinol.

Authors:  Haitian Lu; Barbara L F Kaplan; Thitirat Ngaotepprutaram; Norbert E Kaminski
Journal:  J Leukoc Biol       Date:  2008-11-06       Impact factor: 4.962

9.  CD28 controls differentiation of regulatory T cells from naive CD4 T cells.

Authors:  Fei Guo; Cristina Iclozan; Woong-Kyung Suh; Claudio Anasetti; Xue-Zhong Yu
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

Review 10.  T cell activation.

Authors:  Jennifer E Smith-Garvin; Gary A Koretzky; Martha S Jordan
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.